Insider Trading Activity - Versant Vantage I GP L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Versant Vantage I GP L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-10-28 Sale	2024-10-30 4:35 pm	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	157,895	$9.4432	$1,491,041	7,137,269 (Indirect Direct)	View
2024-09-20 Sale	2024-09-24 4:40 pm	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	1,132,566	$6.5296	$7,395,203	7,197,274 (Indirect Direct)	View
2024-09-11 Sale	2024-09-13 6:44 pm	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	567,213	$6.0027	$3,404,791	8,329,840 (Indirect Direct)	View
2022-06-03 Sale	2022-06-07 4:37 pm	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	750,000	$12.25	$9,188,775	1,233,615 (Indirect Direct)	View
2021-10-18 Sale	2021-10-20 4:38 pm	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	550,000	$14.84	$8,160,736	3,245,533 (Indirect Direct)	View
2021-06-28 Purchase	2021-06-30 5:00 pm	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	157,895	$19	$3,000,005	8,897,053 (Indirect Direct)	View
2020-06-23 Purchase	2020-06-25 7:40 pm	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	250,000	$20	$5,000,000	3,419,451 (Indirect)	View
2020-03-03 Purchase	2020-03-03 7:03 pm	Passage BIO Inc.	PASG	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner	225,000	$18	$4,050,000	4,959,769 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-10-28 Other	2024-10-30 4:35 pm	N/A N/A	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	1,435,402	$0	7,137,269 (Direct)	View
2024-04-09 Conversion	2024-04-11 6:10 pm	N/A N/A	Contineum Therapeutics Inc.	CTNM	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC 10% Owner	5,483,756	$0	10,101,912 (Indirect)	View
Ownership	2024-04-04 9:22 pm	N/A N/A	Contineum Therapeutics Inc.	CTNM	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	0	$0	5,316,663 (Direct)	View
Ownership	2023-09-14 9:17 pm	N/A N/A	RayzeBio Inc.	RYZB	Versant Ventures VII GP-GP LLC Versant Ventures VII GP L.P. Versant Venture Capital VII L.P. Versant Vantage I GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I L.P. 10% Owner	0	$0	5,158,161 (Indirect)	View
2023-01-03 Equity Swap	2023-01-04 6:11 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	3,657,618	$0	0 (Direct)	View
2022-06-06 Other	2022-06-07 4:37 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	992,305	$0	1,233,615 (Indirect)	View
2022-01-05 Other	2022-01-07 4:20 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	253,030	$0	3,547,597 (Indirect)	View
2021-12-21 Other	2021-12-23 4:40 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	253,030	$0	3,548,858 (Indirect)	View
2021-08-05 Other	2021-08-09 4:42 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	156,610	$0	5,156,011 (Direct)	View
2021-06-28 Conversion	2021-06-30 5:00 pm	N/A N/A	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	38,309,520	$0	8,897,053 (Direct)	View
Ownership	2021-06-23 8:29 pm	N/A N/A	Monte Rosa Therapeutics Inc.	GLUE	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	0	$0	8,739,158 (Direct)	View
2021-06-01 Other	2021-06-03 4:32 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	77,247	$0	5,226,427 (Direct)	View
2021-05-12 Other	2021-05-14 4:45 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	404,844	$0	3,736,306 (Indirect)	View
2021-05-05 Other	2021-05-07 4:27 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	341,275	$0	3,397,481 (Indirect)	View
2021-03-26 Other	2021-03-30 7:05 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	404,849	$0	3,738,334 (Indirect)	View
2021-02-17 Other	2021-02-19 5:16 pm	N/A N/A	Oyster Point Pharma Inc.	OYST	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner	337,107	$0	5,604,496 (Direct)	View
2021-02-16 Other	2021-02-18 5:13 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	362,672	$0	3,243,572 (Indirect)	View
2021-01-29 Other	2021-02-02 6:43 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	736,081	$0	1,259,500 (Indirect)	View
2021-01-14 Other	2021-01-19 8:17 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	583,680	$0	1,155,090 (Indirect)	View
2020-12-15 Other	2020-12-17 9:05 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	325,000	$0	4,545,416 (Indirect)	View
2020-07-21 Conversion	2020-07-21 7:41 pm	N/A N/A	Pandion Therapeutics Inc.	PAND	Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	21,530,967	$0	3,754,051 (Direct)	View
Ownership	2020-07-16 8:38 pm	N/A N/A	Pandion Therapeutics Inc.	PAND	Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	0	$0	3,754,051 (Direct)	View
2020-06-23 Conversion	2020-06-25 7:40 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	6,245,349	$0	3,419,451 (Indirect)	View
Ownership	2020-06-18 9:45 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	0	$0	6,987,679 (Indirect)	View
2020-05-18 Other	2020-05-20 9:58 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	120,148	$0	340,301 (Direct)	View
2020-03-03 Conversion	2020-03-03 7:03 pm	N/A N/A	Passage BIO Inc.	PASG	Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner	4,734,769	$0	4,959,769 (Direct)	View
Ownership	2020-02-27 8:07 pm	N/A N/A	Passage BIO Inc.	PASG	Versant Venture Capital VI L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Woiwode Thomas 10% Owner	0	$0	4,734,769 (Direct)	View

Insider Trading & Ownership - Versant Vantage I GP L.P.